Molecular/Structural Biology

J.H. Brown, T.S. Jardetzky, J.C. Gorga, L.J. Stern, R.G. Urban, J.L. Strominger, D.C. Wiley, "Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1," Nature, 364:33-9, 1993. (Cited in 235 publications through December 1994) Comments by Jerry H. Brown This paper is the first description of the three-dimensional structure of a class II human leukocyte antigen (HLA). Also known as histocompatibility antigens, the HLA molecules are present on various cell surfaces t

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Comments by Jerry H. Brown

This paper is the first description of the three-dimensional structure of a class II human leukocyte antigen (HLA). Also known as histocompatibility antigens, the HLA molecules are present on various cell surfaces to help lymphocytes of the immune system recognize and respond to their targets. The structural description of such molecules, explain the authors and other researchers, provides a basis for understanding the molecular mechanisms of such processes as immune recognition.

As far back as 1987, this group of scientists published the first crystal structures of class I HLA molecules (P.J. Bjorkman et al., Nature, 329:506-12, 1987; P.J. Bjorkman et al., Nature, 329:512-8, 1987). But the structure of class II HLA molecules, which are expressed primarily on the surfaces of specialized antigen-presenting cells, such as the macrophages and B lymphocytes, proved more elusive and was not published until nearly five years later, according to the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies